BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 6397697)

  • 1. Magnetic resonance imaging (MRI): method and early clinical experiences in diseases of the central nervous system.
    Huk WJ; Gademann G
    Neurosurg Rev; 1984; 7(4):259-80. PubMed ID: 6397697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance of brain tumors: considerations of imaging contrast on the basis of relaxation measurements.
    Ngo FQ; Bay JW; Kurland RJ; Weinstein MA; Hahn JF; Glassner BJ; Woolley CA; Dudley AW; Ferrario CM; Meaney TF
    Magn Reson Imaging; 1985; 3(2):145-55. PubMed ID: 4033378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rapid nuclear magnetic resonance tomography. Initial results of studies using the new gradient echo sequence].
    Weiss T; Mitsch E; Laniado M; Sander B; Kornmesser W; Deimling M; Felix R
    Rofo; 1987 Feb; 146(2):214-22. PubMed ID: 3029838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of contrast media in MRI at 0.02 T. A preliminary report.
    Kormano M; Niemi P; Paajanen H; Määttänen H; Katevuo K
    Invest Radiol; 1988 Sep; 23 Suppl 1():S289-91. PubMed ID: 3198364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dependence of nuclear magnetic resonance (NMR) image contrast on intrinsic and pulse sequence timing parameters.
    Wehrli FW; MacFall JR; Glover GH; Grigsby N; Haughton V; Johanson J
    Magn Reson Imaging; 1984; 2(1):3-16. PubMed ID: 6530915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system high-resolution magnetic resonance imaging: effect of increasing spatial resolution on resolving power.
    Bradley WG; Kortman KE; Crues JV
    Radiology; 1985 Jul; 156(1):93-8. PubMed ID: 4001426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging: clinical use of the inversion recovery sequence.
    Bydder GM; Young IR
    J Comput Assist Tomogr; 1985; 9(4):659-75. PubMed ID: 2991345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial clinical evaluation of gadolinium DTPA for contrast-enhanced magnetic resonance imaging.
    Runge VM; Schoerner W; Niendorf HP; Laniado M; Koehler D; Claussen C; Felix R; James AE
    Magn Reson Imaging; 1985; 3(1):27-35. PubMed ID: 2987640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear magnetic resonance (NMR) imaging in diseases of the central nervous system: initial results.
    Huk W; Heindel W
    Radiat Med; 1983; 1(2):105-11. PubMed ID: 6679902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gadolinium DTPA in a MR study of expansive lesions of the cranial base].
    Bartolozzi C; Olmastroni M; Dal Pozzo G; Petacchi D
    Radiol Med; 1988 Sep; 76(3):152-7. PubMed ID: 3175068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependence of magnetic resonance image (MRI) intensity values on relaxation times, pulse intervals and other signal attenuation factors.
    Yamanashi WS; Anderson DW; Lester PD; Herrick D; Frazer JW
    Physiol Chem Phys Med NMR; 1985; 17(1):81-100. PubMed ID: 4034683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue characterization of intracranial tumors by magnetization transfer and spin-lattice relaxation parameters in vivo.
    Kurki T; Lundbom N; Komu M; Kormano M
    J Magn Reson Imaging; 1996; 6(4):573-9. PubMed ID: 8835948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumours of the central nervous system. Proton magnetic resonance relaxation times T1 and T2 and histopathologic correlates.
    Englund E; Brun A; Larsson EM; Györffy-Wagner Z; Persson B
    Acta Radiol Diagn (Stockh); 1986; 27(6):653-9. PubMed ID: 3028046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance tomography (MRT) of intracranial tumours: initial experience with the use of the contrast medium Gadolinium-DTPA.
    Schörner W; Kazner E; Laniado M; Sprung C; Felix R
    Neurosurg Rev; 1984; 7(4):303-12. PubMed ID: 6531081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretation of spinal MR images in relation to tissue parameters.
    Vencken LM; Go KG; Kamman RL
    Diagn Imaging Clin Med; 1986; 55(1-2):55-60. PubMed ID: 3635447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of endothelial permeability in brain tumors by dynamic magnetic resonance tomography with magnevist contrast imaging on low-field MR-tomograph].
    Usov VIu; Velichko OB; Borodin OIu; Garganeev AB; Shikunov AA; Boklag ON
    Vestn Rentgenol Radiol; 2001; (3):22-9. PubMed ID: 12717930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced magnetic resonance imaging of tumours of the central nervous system: a clinical review.
    Graif M; Steiner RE
    Br J Radiol; 1986 Sep; 59(705):865-73. PubMed ID: 3756381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging contrast agents: theory and application to the central nervous system.
    Bronen RA; Sze G
    J Neurosurg; 1990 Dec; 73(6):820-39. PubMed ID: 2230966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging in multiple sclerosis.
    Clanet M; Berry I
    Curr Opin Neurol; 1998 Aug; 11(4):299-303. PubMed ID: 9725074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear magnetic resonance of the brain.
    Bydder GM
    Cardiovasc Intervent Radiol; 1986; 8(5-6):264-74. PubMed ID: 3084090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.